Dynamic Light Scattering Spectroscopy of the Human Eye

Chapter 1.  Anatomy of the eye.- Chapter 2.  Light Scattering.- Chapter 3.  Dynamic Light Scattering (DLS).- Chapter 4.  DLS – Animal Experiments.- Chapter 5.  DLS – Human Experiments.- Chapter 6.  DLS in Neurologic diseases - Protocol.- Chapter 7.  DLS in Neurologic diseases – Informed Consent.- Chapter 8.  Patents. 

Blindness or serious vision impairment is one of the most feared disabilities known to humankind. A 2016 report compiled by the National Eye Institute (NEI) of the National Institutes of Health (NIH) and Prevent Blindness America states that although half of all blindness can be prevented, the number of people who suffer vision loss continues to increase. 

The technique of dynamic light scattering (DLS) was developed by physicists in the late 1960s to early 1970s. DLS is now emerging as a potential ophthalmic tool, making possible studies of virtually every tissue and fluid comprising the eye, thus pushing the envelope for broader applications in ophthalmology.

This book presents a comprehensive review of the application of light scattering in clinical use. It is the first of its kind, offering insight to how DLS can be applied to the human eye as well as animals. Chapters discuss DLS in neurological diseases, including protocols, informed consent, and patents. 

Dynamic Light Scattering Spectroscopy of the Human Eye is a must-have resource for physicians, engineers, and physicists interested in the clinical application of DLS to diagnose and potentially treat medical conditions in a non-invasive, quantitative and novel way. 

Jeffrey N. Weiss, MD

The Healing Institute

Margate, FL, USA

Jeffrey N. Weiss, MD is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at the Massachusetts Institute of Technology. He entered college at 16 years of age, and medical school at age 19 on full scholarships. While in medical school he obtained a degree in Electrical Engineering, Magna Cum Laude with distinction, and graduated from Medical School, Summa Cum Laude, at 23 years of age.

Dr. Weiss is the author of more than 100 publications, including 16 books, holds more than 20 U.S. and foreign patents, and has been a Reviewer for multiple scholarly journals. He has served as a Visiting Professor, performed surgery, and lectured nationally and internationally. Dr. Weiss is also the founder of two companies, Ocular Research Associates Inc., and Micron Ophthalmic, Inc. which have manufactured and sold Dr. Weiss’ inventions worldwide.
Dr. Weiss performed the first retinal stem cell surgery in the world in 2010 and is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II, the largest retinal and optic nerve stem cell studies in the world, The Neurologic Stem Cell Treatment Study, The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study, and The Alzheimer’s, Cognitive Impairment and Autism Treatment Study. The studies are Institutional Review Board (IRB) approved, registered with NIH and listed on ClinicalTrials.gov.

Dr. Weiss first visited Dubai in 2008, where equipment he had invented was being showcased at Arab Health, the second largest medical equipment meeting in the world. In 2015, he obtained a Dubai medical license and has been travelling to Dubai to examine patients, perform surgery and lecture. His work has been featured in all the major Dubai newspapers and television. He was a finalist for the United Arab Emirates HealthCare Award in 2018 and 2019.